![]() Boehringer Ingelheim Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing. | ||
Founding Date | Founding Date 1863 | Founding Date 1958 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Ingelheim am Rhein, DE HQ Ouled Fayet, DZ Munro, AR Macquarie Park, AU Wien, AT Minsk, BY Bruxelles, BE see more | |
Employees | Employees 87,7571% decrease | Employees 1,2338% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) €12.7b (FY, 2023) |
Cost of goods | Cost of goods €14b (FY, 2025) | Cost of goods €4b (FY, 2023) |
Gross profit | Gross profit €32.5b (FY, 2025) | Gross profit €8.7b (FY, 2023) |
Net income | Net income (€3.6b) (FY, 2025) | Net income €5.8b (FY, 2023) |
Operating ⚠ | ||
Trademarks | Trademarks 1.5 k (FY, 2021) | Trademarks 5.2 k (Feb, 2024) |

Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing.
View company